Biowatch

Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection

Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection

Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection just once a month.
Samsung Bioepis Expands Global Open Innovation via Partnership With Chinese Biotech Hub

Samsung Bioepis Expands Global Open Innovation via Partnership With Chinese Biotech Hub

Samsung Bioepis announced on the 29th that it has signed a memorandum of understanding with Atlalt Innovation Center, a Chinese biotechnology R&D and...
SCL Group and Hanaro Medical Foundation Accelerate K-Healthcare Expansion into Indonesia

SCL Group and Hanaro Medical Foundation Accelerate K-Healthcare Expansion into Indonesia

SCL Group, a comprehensive healthcare solutions company led by Chairman Lee Kyung-ryul, is set to establish a strategic...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone

Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone

GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.
New Biologic Drug Lands in Korea: Expanded Relief for Chronic Rhinosinusitis and Nasal Polyps

New Biologic Drug Lands in Korea: Expanded Relief for Chronic Rhinosinusitis and Nasal Polyps

A biologic medication previously recognized for its effectiveness in treating severe asthma is now offering a new...
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
The Protein That Erodes Memory: Is ‘Ftl1’ the Key to Reversing Brain Aging?

The Protein That Erodes Memory: Is ‘Ftl1’ the Key to Reversing Brain Aging?

Why does memory fade and the mind slow as the years pass. Addressing this ancient question, a U. S.
Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology

Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology

Rznomics announced on the 30th that a joint study with Professor Hyun-jin Kim’s research team at Inha University has...
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...